FDA issued a Warning Letter to Hameln Pharmaceuticals Gmbh on 12/17/2012 for a previous inspection.
483 Hameln Pharmaceuticals Gmbh Jul 2014

483 Hameln Pharmaceuticals Gmbh Jul 2014

Michael Klapal FDA, Nicole Lloyd FDA$119.00 - Available Now

FDA investigators audited the Hameln Pharmaceuticals Gmbh - Hameln, Germany facility and issued 2 inspectional observations (via FDA 483) on 25 Jul 2014.

Product details

  • Category: Human Drugs
  • Number of Observations: 2
  • Inspection end: 25 Jul 2014
  • Location: Hameln, Germany
  • FEI: 3002807877
Add To Cart